DBS System
Gland
About DBS System
DBS System SA, producer of HemaXis™ blood collection devices, is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes. They produce devices with patented microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis. DBS System is “Unleashing Labs to Stay Well”. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well. HemaXis will help democratize blood collection and support “big data” initiatives important to the development of effective and efficient personalized medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2017)
- Website: dbs-system.ch
- Phone: +410786247015
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/dbs-system-100435 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.